Literature DB >> 23916469

The atypical lipopolysaccharide of Francisella.

Nihal A Okan1, Dennis L Kasper.   

Abstract

Bacterial lipopolysaccharides (LPSs) are ubiquitous molecules that are prominent components of the outer membranes of most gram-negative bacteria. Genetic and structural characterizations of Francisella LPS have revealed substantial differences when compared to more commonly studied LPSs of the Enterobacteriaceae. This review discusses both the general characteristics and the unusual features of Francisella LPS.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2,4-diacetamido-2,4,6-trideoxy-d-glucose; 2-acetamido-2,6-dideoxy-d-glucose; 2-acetamido-2-deoxy-d-galacturonamide; 3-deoxy-d-manno-octulosonic acid; 4,6-dideoxy-4-formamido-d-glucose; Francisella tularensis; GalNAcAN; Kdo; Kdo hydrolase; LPS; Lipid A; Lipopolysachharide; O-antigen; Qui2NAc4NAc; Qui4NFm; QuiNAc; Structure; lipopolysachharide

Mesh:

Substances:

Year:  2013        PMID: 23916469      PMCID: PMC3776585          DOI: 10.1016/j.carres.2013.06.015

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  56 in total

Review 1.  Biosynthesis and assembly of capsular polysaccharides in Escherichia coli.

Authors:  Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

Review 2.  Diversity of endotoxin and its impact on pathogenesis.

Authors:  M Stephen Trent; Christopher M Stead; An X Tran; Jessica V Hankins
Journal:  J Endotoxin Res       Date:  2006

3.  Structural analysis of Francisella tularensis lipopolysaccharide.

Authors:  Evgeny Vinogradov; Malcolm B Perry; J Wayne Conlan
Journal:  Eur J Biochem       Date:  2002-12

4.  Bordetella pertussis waaA encodes a monofunctional 2-keto-3-deoxy-D-manno-octulosonic acid transferase that can complement an Escherichia coli waaA mutation.

Authors:  T Isobe; K A White; A G Allen; M Peacock; C R Raetz; D J Maskell
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

5.  Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors.

Authors:  Adeline M Hajjar; Megan D Harvey; Scott A Shaffer; David R Goodlett; Anders Sjöstedt; Helen Edebro; Mats Forsman; Mona Byström; Mark Pelletier; Christopher B Wilson; Samuel I Miller; Shawn J Skerrett; Robert K Ernst
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

6.  Structure and biosynthesis of free lipid A molecules that replace lipopolysaccharide in Francisella tularensis subsp. novicida.

Authors:  Xiaoyuan Wang; Anthony A Ribeiro; Ziqiang Guan; Sara C McGrath; Robert J Cotter; Christian R H Raetz
Journal:  Biochemistry       Date:  2006-12-05       Impact factor: 3.162

7.  Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp. tularensis.

Authors:  Joann L Prior; Richard G Prior; Paul G Hitchen; Helen Diaper; Kate F Griffin; Howard R Morris; Anne Dell; Richard W Titball
Journal:  J Med Microbiol       Date:  2003-10       Impact factor: 2.472

8.  Novel modification of lipid A of Francisella tularensis.

Authors:  Nancy J Phillips; Birgit Schilling; Molly K McLendon; Michael A Apicella; Bradford W Gibson
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Metabolic labeling to characterize the overall composition of Francisella lipid A and LPS grown in broth and in human phagocytes.

Authors:  Jason H Barker; Justin W Kaufman; De-Sheng Zhang; Jerrold P Weiss
Journal:  Innate Immun       Date:  2013-05-31       Impact factor: 2.680

10.  Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS.

Authors:  G Sandström; A Sjöstedt; T Johansson; K Kuoppa; J C Williams
Journal:  FEMS Microbiol Immunol       Date:  1992-10
View more
  14 in total

Review 1.  Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics.

Authors:  Jacqueline Sharon; Michael J Rynkiewicz; Zhaohua Lu; Chiou-Ying Yang
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

2.  Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Authors:  Jerod A Skyberg; Carolyn A Lacey
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

Review 3.  Microbiome and chronic inflammatory bowel diseases.

Authors:  Jan Wehkamp; Julia-Stefanie Frick
Journal:  J Mol Med (Berl)       Date:  2016-12-17       Impact factor: 4.599

Review 4.  Mechanisms and Consequences of Noncanonical Inflammasome-Mediated Pyroptosis.

Authors:  Skylar S Wright; Swathy O Vasudevan; Vijay A Rathinam
Journal:  J Mol Biol       Date:  2021-09-16       Impact factor: 5.469

Review 5.  Tularemia vaccines.

Authors:  Daniela Putzova; Iva Senitkova; Jiri Stulik
Journal:  Folia Microbiol (Praha)       Date:  2016-05-19       Impact factor: 2.099

6.  Three-dimensional structure of a sugar N-formyltransferase from Francisella tularensis.

Authors:  Alex L Zimmer; James B Thoden; Hazel M Holden
Journal:  Protein Sci       Date:  2014-01-22       Impact factor: 6.725

Review 7.  Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity.

Authors:  Don J Steiner; Yoichi Furuya; Dennis W Metzger
Journal:  Infect Drug Resist       Date:  2014-09-18       Impact factor: 4.003

Review 8.  Innate Immune Recognition: Implications for the Interaction of Francisella tularensis with the Host Immune System.

Authors:  Zuzana Krocova; Ales Macela; Klara Kubelkova
Journal:  Front Cell Infect Microbiol       Date:  2017-10-16       Impact factor: 5.293

Review 9.  Comparative review of Francisella tularensis and Francisella novicida.

Authors:  Luke C Kingry; Jeannine M Petersen
Journal:  Front Cell Infect Microbiol       Date:  2014-03-13       Impact factor: 5.293

Review 10.  From the Outside-In: The Francisella tularensis Envelope and Virulence.

Authors:  Hannah M Rowe; Jason F Huntley
Journal:  Front Cell Infect Microbiol       Date:  2015-12-23       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.